HK1164702A1 - Composition with improved bioavailability of saponin - Google Patents

Composition with improved bioavailability of saponin

Info

Publication number
HK1164702A1
HK1164702A1 HK12105384.9A HK12105384A HK1164702A1 HK 1164702 A1 HK1164702 A1 HK 1164702A1 HK 12105384 A HK12105384 A HK 12105384A HK 1164702 A1 HK1164702 A1 HK 1164702A1
Authority
HK
Hong Kong
Prior art keywords
saponin
composition
improved bioavailability
bioavailability
improved
Prior art date
Application number
HK12105384.9A
Other languages
English (en)
Chinese (zh)
Inventor
田熙英
李知海
朱璟美
朴贊雄
林慶珉
徐大方
李尚駿
Original Assignee
株式會社愛茉莉太平洋
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式會社愛茉莉太平洋 filed Critical 株式會社愛茉莉太平洋
Publication of HK1164702A1 publication Critical patent/HK1164702A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
HK12105384.9A 2009-05-26 2012-06-01 Composition with improved bioavailability of saponin HK1164702A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090045858A KR101593618B1 (ko) 2009-05-26 2009-05-26 사포닌의 생체 이용률 증진 조성물
PCT/KR2010/003288 WO2010137846A2 (ko) 2009-05-26 2010-05-25 사포닌의 생체 이용률 증진 조성물

Publications (1)

Publication Number Publication Date
HK1164702A1 true HK1164702A1 (en) 2012-09-28

Family

ID=43223223

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105384.9A HK1164702A1 (en) 2009-05-26 2012-06-01 Composition with improved bioavailability of saponin

Country Status (7)

Country Link
US (1) US10172900B2 (xx)
EP (1) EP2436388B1 (xx)
JP (2) JP6055309B2 (xx)
KR (1) KR101593618B1 (xx)
CN (2) CN104688791B (xx)
HK (1) HK1164702A1 (xx)
WO (1) WO2010137846A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101593618B1 (ko) * 2009-05-26 2016-02-15 (주)아모레퍼시픽 사포닌의 생체 이용률 증진 조성물
KR101326005B1 (ko) * 2011-04-29 2013-11-07 재단법인 진안홍삼연구소 홍삼 농축액 및 과일 농축액을 함유하는 기능성 음료 조성물
EP2982377B1 (en) * 2013-04-02 2023-06-07 Amorepacific Corporation Ginseng berry extract for use in alleviating menopausal symptoms
WO2015005554A1 (ko) * 2013-07-11 2015-01-15 (주)아모레퍼시픽 발모 및 육모 촉진용 조성물
CN104509909B (zh) * 2014-12-29 2016-09-07 通化百泉保健食品有限公司 人参、百合复合保健饮料及制备方法
CN104509926B (zh) * 2014-12-29 2016-08-24 通化百泉保健食品有限公司 人参、麦冬复合保健饮料及制备方法
CN104509912B (zh) * 2014-12-29 2016-12-07 通化百泉保健食品有限公司 人参、山胡萝卜复合保健饮料及制备方法
CN105031212B (zh) * 2015-07-07 2018-04-17 广东药学院 一种治疗帕金森病的药物
DE102015217418A1 (de) 2015-09-11 2017-03-16 Mühlbauer Technology Gmbh Radikalisch polymerisierbares Dentalmaterial
EP3308765B1 (de) 2016-10-17 2022-07-13 Mühlbauer Technology GmbH Radikalisch polymerisierbare verbindung
KR102505329B1 (ko) * 2022-10-17 2023-03-07 대동고려삼 주식회사 인지기능 개선 효과가 있는 소재를 이용한 홍삼 가공식품의 제조방법

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3142197B2 (ja) 1993-11-17 2001-03-07 ポーラ化成工業株式会社 人参サポニン製造法
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH11349487A (ja) * 1998-06-03 1999-12-21 Kwang Dong Pharmaceut Co Ltd 新しい処方の牛黄清心元組成物及びその製造方法
CN1116894C (zh) 1999-03-09 2003-08-06 中国药科大学 治疗心血管病的药物
KR100364000B1 (ko) * 2000-04-26 2002-12-12 정풍한방제약주식회사 스포츠 음료 조성물 및 이의 제조 방법
JP2002275086A (ja) * 2001-03-15 2002-09-25 Fancl Corp 虚弱体質改善用組成物
KR100425022B1 (ko) 2002-01-05 2004-03-27 롯데제과주식회사 가공인삼 추출물 및 이를 함유하는 약제 조성물
KR100555652B1 (ko) 2002-04-08 2006-11-10 주식회사 진생사이언스 약효가 증강된 파낙스속 식물의 가공 추출물, 그 제조방법및 그를 함유하는 암 및 알러지 질환의 예방 및 치료를위한 조성물
WO2003086438A1 (en) * 2002-04-08 2003-10-23 Ginseng Science Inc. Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
KR100479803B1 (ko) 2002-04-08 2005-03-30 홍림통산(주) 약효가 증가된 특수가공처리 인삼 추출물을 함유하는뇌졸증의 예방 및 치료를 위한 조성물
JP3678362B2 (ja) * 2002-07-23 2005-08-03 長谷川 秀夫 サポニン分解物を含有する発酵人参の製造法
KR100572621B1 (ko) * 2003-03-19 2006-04-24 한국 한의학 연구원 비만 및 성인병 치료용 조성물
CN1234370C (zh) 2003-09-30 2006-01-04 广州欧华医药生物技术有限公司 一种治疗心血管疾病和休克急救的中药注射剂
JP2007510000A (ja) * 2003-11-07 2007-04-19 コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ 植物抽出物ならびに該抽出物の医薬品および化粧品における使用
CN1296048C (zh) 2003-12-19 2007-01-24 江苏正大天晴药业股份有限公司 参麦总皂甙滴丸及其制备方法
CN1317010C (zh) 2005-03-08 2007-05-23 北京正大绿洲医药科技有限公司 一种用于强心益肾的滴丸及其制备方法
KR100692519B1 (ko) 2005-03-17 2007-03-09 주식회사고려원인삼 냉온음료용 과립 홍삼 생맥산 및 이의 제조방법
WO2006115307A1 (en) * 2005-04-26 2006-11-02 Ko, Boong-Kyung Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof
CN1868504A (zh) 2005-05-24 2006-11-29 上海祥鹤制药厂 一种维肝福泰胶囊的制备方法
CN1939505A (zh) * 2005-09-26 2007-04-04 刘凤鸣 生脉饮滴丸及其制备方法
US7419689B2 (en) * 2005-11-15 2008-09-02 Access Business Group International Llc. Plant-based formulations for improving liver health
KR101234605B1 (ko) 2005-11-24 2013-02-22 대동고려삼 주식회사 흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼
CN101024034A (zh) 2006-02-20 2007-08-29 陈文展 参芪消渴滴丸
JP2008100999A (ja) * 2006-10-18 2008-05-01 In-Hwan Seong ジンセノサイド成分含量の多い人参果実と人参花柄の製造方法
CN101028437B (zh) 2007-04-03 2011-05-04 中国药科大学 一种防治心脑血管疾病的中药有效部位组合物及制备方法
KR100823940B1 (ko) * 2007-10-26 2008-04-22 (주)청구바이오 인삼 열매를 이용한 식품과 그 제조방법
KR101593618B1 (ko) * 2009-05-26 2016-02-15 (주)아모레퍼시픽 사포닌의 생체 이용률 증진 조성물

Also Published As

Publication number Publication date
US10172900B2 (en) 2019-01-08
EP2436388B1 (en) 2016-03-23
JP2012528144A (ja) 2012-11-12
US20120076874A1 (en) 2012-03-29
JP2015164955A (ja) 2015-09-17
JP6053873B2 (ja) 2016-12-27
WO2010137846A3 (ko) 2011-03-31
CN104688791A (zh) 2015-06-10
CN102458434A (zh) 2012-05-16
WO2010137846A2 (ko) 2010-12-02
EP2436388A4 (en) 2012-11-28
CN102458434B (zh) 2015-03-25
JP6055309B2 (ja) 2016-12-27
KR20100127420A (ko) 2010-12-06
EP2436388A2 (en) 2012-04-04
KR101593618B1 (ko) 2016-02-15
CN104688791B (zh) 2018-04-27

Similar Documents

Publication Publication Date Title
HK1164702A1 (en) Composition with improved bioavailability of saponin
GB0908129D0 (en) Composition
GB0918450D0 (en) Composition
GB0905863D0 (en) Novel composition
GB0911428D0 (en) Composition
GB0909362D0 (en) Composition
GB0908642D0 (en) Composition
HK1164356A1 (en) Composition
IL216395A0 (en) Prothrombic complex composition
EP2394634A4 (en) HESPERIDO-CONTAINING COMPOSITION
GB0906779D0 (en) Composition
GB0922389D0 (en) composition
GB0911294D0 (en) Composition
GB0904941D0 (en) Composition
EP2444061A4 (en) COMPOSITION CONTAINING APIGENIN
GB201006350D0 (en) Composition
GB0904942D0 (en) Composition
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
GB0918590D0 (en) Composition
GB0903688D0 (en) Composition
GB0922133D0 (en) Composition
GB0912768D0 (en) Novel composition
GB0902959D0 (en) Composition
GB0902917D0 (en) Composition
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE